Webb L M, Foxwell B M, Feldmann M
Kennedy Institute of Rheumatology, Hammersmith, London, UK.
Immunology. 1999 Nov;98(3):400-5. doi: 10.1046/j.1365-2567.1999.00906.x.
The capacity of the immune system to respond efficiently to new antigens depends upon a continuous source of naive CD4+ T cells. Such cells exit from the thymus and join the recirculated T-cell pool. Factors present at the sites of naive CD4+ T-cell circulation must be responsible for their survival, since upon removal from their host, naive CD4+ T cells die. However, such factors remain unknown. The presence of the cytokine interleukin-7 (IL-7) in secondary lymphoid organs and the continuous expression of its receptor on naive CD4+ T cells prompted us to examine the possibility that IL-7 might be a survival factor for naive CD4+ T cells. Using naive CD4+ T cells isolated from cord blood we show that IL-7, but not IL-2, can maintain naive CD4+ T-cell viability in vitro for at least 15 days. In addition, we find that IL-7 can induce modest proliferation of naive CD4+ T cells without affecting either their cell surface phenotype or their ability to respond to antigenic stimulation. We also find that after anti-CD3 stimulation, naive CD4+ T cells lose that ability to respond to IL-7. However, if cells are primed with IL-7 prior to antigenic stimulation, their proliferative responses are enhanced. Together, these data suggest a novel and important role for IL-7 in the maintenance and maturation of naive CD4+ T cells, ensuring that they can respond maximally when they first meet antigen in secondary lymphoid tissue.
免疫系统有效应对新抗原的能力取决于持续供应的初始CD4+ T细胞。此类细胞从胸腺输出并加入再循环的T细胞库。初始CD4+ T细胞循环部位存在的因素必定对其存活负责,因为从宿主中移除后,初始CD4+ T细胞会死亡。然而,此类因素仍不明确。次级淋巴器官中存在细胞因子白细胞介素-7(IL-7),且其受体在初始CD4+ T细胞上持续表达,这促使我们研究IL-7可能是初始CD4+ T细胞存活因子的可能性。使用从脐带血中分离出的初始CD4+ T细胞,我们发现IL-7而非IL-2能够在体外维持初始CD4+ T细胞活力至少15天。此外,我们发现IL-7能够诱导初始CD4+ T细胞适度增殖,而不影响其细胞表面表型或对抗抗原刺激的反应能力。我们还发现,抗CD3刺激后,初始CD4+ T细胞失去对IL-7的反应能力。然而,如果细胞在抗原刺激前用IL-7预处理,其增殖反应会增强。总之,这些数据表明IL-7在初始CD4+ T细胞的维持和成熟中具有新的重要作用,确保它们在次级淋巴组织中首次遇到抗原时能够做出最大反应。